| Trial ID: | L0337 |
| Source ID: | NCT00852969
|
| Associated Drug: |
Niacin
|
| Title: |
Niacin and Endothelial Function in Early CKD
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00852969/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Niacin|DRUG: Active Placebo
|
| Outcome Measures: |
Primary: Change in the Flow Mediated Dilation From Baseline, Flow mediated dilation by brachial artery reactivity at baseline versus 14 weeks, 14 weeks since baseline | Secondary: Change in HDL-C From Baseline to 14 Weeks, 14 weeks since baseline
|
| Sponsor/Collaborators: |
Sponsor: Tufts Medical Center | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-08
|
| Completion Date: |
2012-04
|
| Results First Posted: |
2014-05-06
|
| Last Update Posted: |
2014-05-06
|
| Locations: |
Tufts Medical Center, Boston, Massachusetts, 02111, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00852969
|
